itraconazole has been researched along with Adult Spinal Muscular Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al Kotbi, N; Bergauer, T; Cleary, Y; Czech, C; Frances, N; Günther, A; Heinig, K; Jaber, B; Jordan, P; Khwaja, O; Kletzl, H; Marquet, A; Müller, L; Parkar, N; Poirier, A; Ratni, H; Sturm, S | 1 |
1 trial(s) available for itraconazole and Adult Spinal Muscular Atrophy
Article | Year |
---|---|
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Azo Compounds; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Male; Middle Aged; Muscular Atrophy, Spinal; Neuromuscular Agents; Pyrimidines; RNA Splicing; RNA, Messenger; Survival of Motor Neuron 2 Protein; Young Adult | 2019 |